CERTIFIED HEALTH IT PRODUCT LIST (CHPL) PRODUCT NUMBER: 15.04.04.3138.IMAT.08.00.0.221230
DEVELOPER REAL WORLD TESTING PLAN PAGE URL: https://imatsolutions.com/index.php/ecqm/real-world-testing/
IMAT Solutions is a certified Data Aggregator Vendor, therefore, the scope of the Real World Testing focused on the QRDAs created based on data received by IMAT Solutions from certified EHRs that support providers/clinicians that have an interface to IMAT Solutions. IMAT’s eCQM measures currently support over 1,000 clinicians, that will extend to over 1,500 clinicians by the end of 2025, and several high volume MCOs (Managed Care Organizations). These clinicians and MCOs participate in the CMS Quality Payment Program (QPP), HEDIS Reporting and CMS
eCQM reporting. Additionally, the data within IMAT Solutions also support extracts and Quality Dashboards for MCOs, providers and specific State Quality Dashboards.
IMAT Solutions receives data via FHIR API, QRDA1s, CCDs, proprietary flat files etc.. and then calculates eCQM measure results, produces any needed submission files (ex: QRDA III), publishes results to performance dashboards, and provides detailed analysis on customers’ submission readiness (gaps in care, data formatting issues, etc.)
IMATs objective with these quality and regulatory reporting products is to ensure 100% successful submission on behalf of our customers. IMATs C3 technology allows IMAT to transmit certified data to customers throughout the reporting year. Customers can also login, to run quality measures on demand for any specified time period, to view measure results on-demand. IMAT also provides year round, white-glove service to identify and address any data issues negatively impacting performance results or submission.
IMAT – 15.04.04.3138.IMAT.08.00.0.221230 supports the following standards for
170.315(c2);(c3)
2024 CMS QRDA I Implementation Guide for Hospital Quality Reporting (170.205(h)(3))
• Method used for standard update: SVAP
• Date notification sent to ONC-ACB: December 15th, 2022
• Date notification sent to customers: July 12th, 2023
• Measure used to demonstrate: Cypress with Drummond supervision
2024 CMS QRDA III Implementation Guide for Eligible Clinicians (170.205(k)(3))
• Method used for standard update: SVAP
• Date notification sent to ONC-ACB: December 15th, 2022
• Date notification sent to customers: July 12th, 2023
• Measure used to demonstrate: Cypress with Drummond supervision
Testing was carried out by deploying the relevant modules in a live environment for use in submission of the QRDAIII files. Test participants included certified healthcare professionals and IMAT Solutions Inc. The system was evaluated based on its usability, accuracy, security, and compliance with the specified criteria.
To validate that the Clinical Quality Measures (CQMs) functionalities for both the “Import and Calculate” and “Report” modules meet the requirements specified in the certification criteria 170.315(c)(2) and 170.315(c)(3). This test plan evaluates the software’s ability to:
1. Import and calculate certified eCQMs correctly according to the measure specifications.
2. Generate reports based on the eCQMs IMAT has certified and provide the required data output.
Count of patients that IMAT has received QRDA I records or other clinical data for that were represented in the generated QRDA III records.
Modules: 170.315(c)(2),(c)(3)
Shows IMATs ability to generate QRDA III records for use in submissions to CMS and TJC
IMAT has received certification through NCQA as Validated Data Stream under their Data Aggregator Validation(DAV) program. IMAT will focus on care settings which have been validated under the DAV program. This currently includes the Outpatient Care and Outpatient Lab care settings.
Pass/Fail: Pass
Count of patients that IMAT has received QRDA I records or other clinical data for that were represented in the generated QRDA III records: 81051
Details: The system successfully imported the data without any issues. No errors were encountered during the import process. Data is correctly displayed within IMAT.
Companion measure used to track the percentage of QRDA III’s that were generated. This was used to track quality issues that could affect reporting.
Modules: 170.315(c)(2),(c)(3)
Tracks the quality of data generated
IMAT has received certification through NCQA as Validated Data Stream under their Data Aggregator Validation(DAV) program. IMAT will focus on care settings which have been validated under the DAV program. This currently includes the Outpatient Care and Outpatient Lab care settings.
Pass/Fail: Pass
Percentage: 100%
Details: The system successfully generated CQM reports in the required format. All required data points were included and formatted correctly. The report generation was completed within an acceptable time frame.
Challenges encountered: Receiving up-to-date information from our ingestion sites about which providers should be included in the QRDAIII file for export. NPI/TIN warnings are displayed upon submission if all relevant providers are not included in the file export.
Companion measure used to track the stability of the product across each eCQM measure. The success of the product relies on the ability to produce useful data that can be submitted to CMS and TJC
Modules: 170.315(c)(2),(c)(3)
Tracks the quality of the product submitting data to CMS and TJC
IMAT has received certification through NCQA as Validated Data Stream under their Data Aggregator Validation (DAV) program. IMAT will focus on care settings which have been validated under the DAV program. This currently includes the Outpatient Care and Outpatient Lab care settings.
Pass/Fail: Pass
Issues found across all eCQMs: 0
Details: Calculations for all tested CQMs were accurate and consistent with expected outcomes. Results were verified against sample calculations to ensure correctness.
Starting January 1st 2025 – Patient data which belongs to a Care settings covered by the DAV program was used to calculate data for the eCQM measure which we are certified on and QRDA III’s were created. Data was collected from this point to be used in the Real World Testing measures communicated in this document.
On or before December 31st 2025 – IMAT collected and gathered all generated data for each respective measure in the Real World Testing plan, and compiled results and outcomes from the test plan.
This Real-World Testing Results report is complete with all required elements, including measures that address all certification criteria and care settings. All information in this plan is up to date and fully addresses the health IT developer’s Real World Testing requirements.
Authorized Rep Name: Laurel Havenner
Authorized Rep Email: laurel.havenner@imatsolutions.com
Authorized Rep Phone: 844-772-6258
Authorized Rep Signature: Laurel Havenner
Date: 1/31/2025